Literature DB >> 27179992

Comparison of kinetic and pharmacological profiles of recombinant α1γ2L and α1β2γ2L GABAA receptors - A clue to the role of intersubunit interactions.

Marek Brodzki1, Radoslaw Rutkowski2, Magdalena Jatczak3, Magdalena Kisiel2, Marta M Czyzewska2, Jerzy W Mozrzymas3.   

Abstract

The fastest inhibitory mechanism in the CNS is mediated by ionotropic GABAA receptors and it is known that subunit composition critically determines their properties. While a typical GABAA receptor consists of two α, two β and one γ/δ subunit, there are some exceptions, e.g. αβ receptors. Functional α1γ2 GABAA receptors can be expressed in recombinant model (Verdoorn et al., 1990) and although their role remains unknown, it seems appealing to extend their characterization to further explore the structure-function relationship of GABAA receptors. Intriguingly, this receptor is lacking canonical GABA binding sites but it can be activated by GABA and dose-response relationships for α1β2γ2L and α1γ2L receptors overlap. Deactivation kinetics was similar for both receptors but the percentage of the fast component was smaller in the case of α1γ2L receptors and, consequently, the mean deactivation time constant was slower. The rate and extent of macroscopic desensitization were smaller in the case of α1γ2L receptors but they showed slower recovery. Both receptor types had a similar proton sensitivity showing only subtle but significant differences in pH effects on deactivation. Flurazepam exerted a similar effect on both receptors but the rapid deactivation components were differently affected and an opposite effect was observed on desensitization extent. Rebound currents evoked by pentobarbital were undistinguishable for both receptor types. Taking altogether, although some significant differences were found, α1β2γ2L and α1γ2L receptors showed unforeseen similarity. We propose that functioning of GABAA receptors might rely on subunit-subunit cooperative interactions to a larger extent than believed so far.
Copyright © 2016 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Flurazepam (PubChem CID: 14434); GABA (PubChem CID: 119); GABA(A) receptor; Intersubunit interactions; Kinetics; Pentobarbital (PubChem CID: 23676152); Pharmacology; Subunit stoichiometry

Mesh:

Substances:

Year:  2016        PMID: 27179992     DOI: 10.1016/j.ejphar.2016.05.015

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  3 in total

1.  Distinct Modulation of Spontaneous and GABA-Evoked Gating by Flurazepam Shapes Cross-Talk Between Agonist-Free and Liganded GABAA Receptor Activity.

Authors:  Magdalena Jatczak-Śliwa; Katarzyna Terejko; Marek Brodzki; Michał A Michałowski; Marta M Czyzewska; Joanna M Nowicka; Anna Andrzejczak; Rakenduvadhana Srinivasan; Jerzy W Mozrzymas
Journal:  Front Cell Neurosci       Date:  2018-08-28       Impact factor: 5.505

2.  α1 Subunit Histidine 55 at the Interface between Extracellular and Transmembrane Domains Affects Preactivation and Desensitization of the GABAA Receptor.

Authors:  Przemyslaw T Kaczor; Aleksandra D Wolska; Jerzy W Mozrzymas
Journal:  ACS Chem Neurosci       Date:  2021-01-20       Impact factor: 4.418

3.  Predicted Biological Activity of Purchasable Chemical Space.

Authors:  John J Irwin; Garrett Gaskins; Teague Sterling; Michael M Mysinger; Michael J Keiser
Journal:  J Chem Inf Model       Date:  2017-12-29       Impact factor: 4.956

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.